- University of Chicago, Chicago, Illinois – MD
- Johns Hopkins Hospital, Baltimore, Maryland – Residency in Internal Medicine
- Johns Hopkins Hospital, - Fellowship in Cardiology
- University of Chicago – PhD in Pharmacological & Physiological Sciences
Dr. Kamp is a faculty member in the Division of Cardiovascular Medicine within the Department of Medicine. He is also a professor in the Department of Cell and Regenerative Biology, a Herman and Aileen Tuchman Chair in Cardiology, and director of the Stem Cell and Regenerative Medicine Center. His teaching activities focus on cardiac physiology and pharmacology. In 2012, he received the Cozzarelli Prize for outstanding article in Proceedings of National Academies of Sciences that recognizes outstanding contributions to the scientific disciplines represented by the National Academy of Sciences. In 2017, Dr. Kamp received the Rankin Research Award, given to a senior member of the Medicine faculty who has made a significant research contribution toward advancing the field of medicine.
Dr. Kamp is a member of numerous academic societies such as the American Association for the Advancement of Science, American College of Cardiology and the International Society for Heart Research. He is a fellow of the American College of Cardiology and the American Heart Association.
Dr. Kamp's clinical activities include general cardiology with an emphasis on noninvasive cardiac electrophysiology and heart failure. He directs an active research program which bridges from the basic functional and electrical properties of heart cells to clinical applications arising from these basic studies, including the use of stem cells to repair damaged heart muscle.
Dr. Kamp’s research focuses on ion channel proteins in the heart, the coupling of cardiac electrical activity to mechanical contraction, and the molecular mechanisms underlying heart failure. In addition, more recent efforts have focused on applications of stem cells in cardiovascular research and therapy. A variety of research approaches are employed including cellular electrophysiology, cell culture, molecular biology, pharmacology, biochemistry, transgenic animal models, and animal models of heart failure. He has been an investigator in several clinical trials of antiarrhythmic drug treatment for atrial fibrillation.
Dr. Kamp participates widely in peer-review activities, including being on the editorial board for Circulation Research and being a regular reviewer for multiple cardiovascular-related journals. Kamp has served on multiple peer review panels including the American Heart Association National Committee on Cellular Cardiovascular Physiology and Pharmacology and multiple ad hoc National Institutes of Health study sections.